TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT02565901

Sirolimus, Docetaxel, and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer

Cause of deathFunding or business Automatic label, confidence 0.9, unverified. How labels are made.
“Terminated due to insufficient funding”

The sponsor’s own words in the registry.

Life of this trial

20152016201720182019202020212022Registered2015-09-25Started2016-02-29Stopped2020-06-16Results posted2021-10-01

Vital statistics

Status
Terminated
Phase
Phase 1, Phase 2
Sponsor
University of Washington
Sponsor type
University, hospital or other
Conditions
Castration-Resistant Prostate Carcinoma; Metastatic Prostate Carcinoma; Stage IV Prostate Cancer AJCC v7; Metastatic Malignant Neoplasm in the Bone
Interventions
Carboplatin; Docetaxel; Laboratory Biomarker Analysis; Sirolimus
Participants
28
Sites
1
Countries
United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.